Resultados econômicos

Restrictive blood transfusion practices are associated with improved patient outcomes. (abre nova janela)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Fonte‎: Transfusion 2014;54(10 Pt 2):2753-9.

Indexado‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (abre nova janela)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (abre nova janela)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Fonte‎: Transfusion 2017;57(6):1347-58.

Indexado‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (abre nova janela)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (abre nova janela)

MacLaren R, Sullivan PW.

Fonte‎: Value Health 2005;8(2):105-16.

Indexado‎: PubMed 15804319

DOI‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (abre nova janela)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (abre nova janela)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Fonte‎: Transfusion 2015;55(12):2807-15.

Indexado‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (abre nova janela)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (abre nova janela)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Fonte‎: Crit Care 2015;19:83.

Indexado‎: PubMed 25880548

DOI‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (abre nova janela)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (abre nova janela)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Fonte‎: Health Technol Assess 2013;17(10):1-79.

Indexado‎: PubMed 23477634

DOI‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (abre nova janela)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (abre nova janela)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Fonte‎: J Trauma 2009;66(1):63-72.

Indexado‎: PubMed 19131807

DOI‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (abre nova janela)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (abre nova janela)

Zilberberg MD, Shorr AF.

Fonte‎: BMC Health Serv Res 2007;7:138.

Indexado‎: PubMed 17764560

DOI‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (abre nova janela)

TERAPIA INTENSIVA E DE EMERGÊNCIA

Resultados econômicos

Português (Brasil)

Resultados econômicos

https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (abre nova janela)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (abre nova janela)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (abre nova janela)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (abre nova janela)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (abre nova janela)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (abre nova janela)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (abre nova janela)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (abre nova janela)

Contate um representante da Comissão de Ligação com Hospitais

Conteúdos para baixar

Vídeos

Resultados econômicos

Selecione seu idioma

Compartilhar